Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1395166

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1395166

Global Testosterone Replacement Therapy Market 2024-2028

PUBLISHED:
PAGES: 167 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Abstract

The testosterone replacement therapy market is forecasted to grow by USD 497.67 mn during 2023-2028, accelerating at a CAGR of 3.7% during the forecast period. The report on the testosterone replacement therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising initiatives to increase awareness about hypogonadism among people, rise in prevalence of chronic diseases, and increasing aging population and postmenopausal women.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20243.13%
CAGR3.7%
Incremental Value$497.67mn

Technavio's testosterone replacement therapy market is segmented as below:

By Distribution Channel

  • Hospitals
  • Retail
  • Online

By Product

  • Injectables
  • Topicals
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rise in novel therapeutic approaches for testosterone replacement therapy as one of the prime reasons driving the testosterone replacement therapy market growth during the next few years. Also, increasing patient assistance programs and growing advancements in testosterone replacement therapy market will lead to sizable demand in the market.

The report on the testosterone replacement therapy market covers the following areas:

  • Testosterone replacement therapy market sizing
  • Testosterone replacement therapy market forecast
  • Testosterone replacement therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading testosterone replacement therapy market vendors that include AbbVie Inc., Acerus Pharmaceuticals Corp., Actiza Pharmaceutical Pvt. Ltd., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Eli Lilly and Co., Endo International Plc, Ferring BV, Halozyme Therapeutics Inc., Insud Pharma S.L, Lupin Ltd., Marius Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Acrux Ltd., Alvogen Iceland ehf, and Sawai Pharmaceutical Co. Ltd.. Also, the testosterone replacement therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR45364

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global testosterone replacement therapy market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global testosterone replacement therapy market 2018 - 2022 ($ million)
  • 4.2 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • 4.3 Product Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 32: Chart on Comparison by Distribution Channel
  • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Hospitals - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • 6.4 Retail - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
  • 6.5 Online - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Distribution Channel
  • Exhibit 46: Market opportunity by Distribution Channel ($ million)
  • Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 48: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
  • Exhibit 50: Chart on Comparison by Product
  • Exhibit 51: Data Table on Comparison by Product
  • 7.3 Injectables - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on Injectables - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
  • 7.4 Topicals - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Topicals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 57: Data Table on Topicals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 58: Chart on Topicals - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
  • 7.5 Others - Market size and forecast 2023-2028
  • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by Product
  • Exhibit 64: Market opportunity by Product ($ million)
  • Exhibit 65: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Canada - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
  • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 UK - Market size and forecast 2023-2028
  • Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.11 China - Market size and forecast 2023-2028
  • Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 AbbVie Inc.
  • Exhibit 115: AbbVie Inc. - Overview
  • Exhibit 116: AbbVie Inc. - Product / Service
  • Exhibit 117: AbbVie Inc. - Key news
  • Exhibit 118: AbbVie Inc. - Key offerings
  • 12.4 Acerus Pharmaceuticals Corp.
  • Exhibit 119: Acerus Pharmaceuticals Corp. - Overview
  • Exhibit 120: Acerus Pharmaceuticals Corp. - Product / Service
  • Exhibit 121: Acerus Pharmaceuticals Corp. - Key offerings
  • 12.5 Alembic Pharmaceuticals Ltd.
  • Exhibit 122: Alembic Pharmaceuticals Ltd. - Overview
  • Exhibit 123: Alembic Pharmaceuticals Ltd. - Product / Service
  • Exhibit 124: Alembic Pharmaceuticals Ltd. - Key offerings
  • 12.6 Amneal Pharmaceuticals Inc.
  • Exhibit 125: Amneal Pharmaceuticals Inc. - Overview
  • Exhibit 126: Amneal Pharmaceuticals Inc. - Business segments
  • Exhibit 127: Amneal Pharmaceuticals Inc. - Key news
  • Exhibit 128: Amneal Pharmaceuticals Inc. - Key offerings
  • Exhibit 129: Amneal Pharmaceuticals Inc. - Segment focus
  • 12.7 Bausch Health Companies Inc.
  • Exhibit 130: Bausch Health Companies Inc. - Overview
  • Exhibit 131: Bausch Health Companies Inc. - Business segments
  • Exhibit 132: Bausch Health Companies Inc. - Key news
  • Exhibit 133: Bausch Health Companies Inc. - Key offerings
  • Exhibit 134: Bausch Health Companies Inc. - Segment focus
  • 12.8 Bayer AG
  • Exhibit 135: Bayer AG - Overview
  • Exhibit 136: Bayer AG - Business segments
  • Exhibit 137: Bayer AG - Key news
  • Exhibit 138: Bayer AG - Key offerings
  • Exhibit 139: Bayer AG - Segment focus
  • 12.9 Cipla Ltd.
  • Exhibit 140: Cipla Ltd. - Overview
  • Exhibit 141: Cipla Ltd. - Business segments
  • Exhibit 142: Cipla Ltd. - Key news
  • Exhibit 143: Cipla Ltd. - Key offerings
  • Exhibit 144: Cipla Ltd. - Segment focus
  • 12.10 Eli Lilly and Co.
  • Exhibit 145: Eli Lilly and Co. - Overview
  • Exhibit 146: Eli Lilly and Co. - Product / Service
  • Exhibit 147: Eli Lilly and Co. - Key news
  • Exhibit 148: Eli Lilly and Co. - Key offerings
  • 12.11 Endo International Plc
  • Exhibit 149: Endo International Plc - Overview
  • Exhibit 150: Endo International Plc - Business segments
  • Exhibit 151: Endo International Plc - Key news
  • Exhibit 152: Endo International Plc - Key offerings
  • Exhibit 153: Endo International Plc - Segment focus
  • 12.12 Ferring BV
  • Exhibit 154: Ferring BV - Overview
  • Exhibit 155: Ferring BV - Product / Service
  • Exhibit 156: Ferring BV - Key offerings
  • 12.13 Halozyme Therapeutics Inc.
  • Exhibit 157: Halozyme Therapeutics Inc. - Overview
  • Exhibit 158: Halozyme Therapeutics Inc. - Product / Service
  • Exhibit 159: Halozyme Therapeutics Inc. - Key offerings
  • 12.14 Marius Pharmaceuticals
  • Exhibit 160: Marius Pharmaceuticals - Overview
  • Exhibit 161: Marius Pharmaceuticals - Product / Service
  • Exhibit 162: Marius Pharmaceuticals - Key offerings
  • 12.15 Pfizer Inc.
  • Exhibit 163: Pfizer Inc. - Overview
  • Exhibit 164: Pfizer Inc. - Product / Service
  • Exhibit 165: Pfizer Inc. - Key news
  • Exhibit 166: Pfizer Inc. - Key offerings
  • 12.16 Sawai Pharmaceutical Co. Ltd.
  • Exhibit 167: Sawai Pharmaceutical Co. Ltd. - Overview
  • Exhibit 168: Sawai Pharmaceutical Co. Ltd. - Business segments
  • Exhibit 169: Sawai Pharmaceutical Co. Ltd. - Key offerings
  • Exhibit 170: Sawai Pharmaceutical Co. Ltd. - Segment focus
  • 12.17 Teva Pharmaceutical Industries Ltd.
  • Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 176: Inclusions checklist
  • Exhibit 177: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 178: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 179: Research methodology
  • Exhibit 180: Validation techniques employed for market sizing
  • Exhibit 181: Information sources
  • 13.5 List of abbreviations
  • Exhibit 182: List of abbreviations
Product Code: IRTNTR45364

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global testosterone replacement therapy market 2018 - 2022 ($ million)
  • Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Distribution Channel
  • Exhibits33: Data Table on Comparison by Distribution Channel
  • Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Retail - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Retail - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Retail - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibits43: Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibits44: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by Distribution Channel ($ million)
  • Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits48: Chart on Product - Market share 2023-2028 (%)
  • Exhibits49: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits50: Chart on Comparison by Product
  • Exhibits51: Data Table on Comparison by Product
  • Exhibits52: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Injectables - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Topicals - Market size and forecast 2023-2028 ($ million)
  • Exhibits57: Data Table on Topicals - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Chart on Topicals - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Market opportunity by Product ($ million)
  • Exhibits65: Data Table on Market opportunity by Product ($ million)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ million)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits109: Impact of drivers and challenges in 2023 and 2028
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: AbbVie Inc. - Overview
  • Exhibits116: AbbVie Inc. - Product / Service
  • Exhibits117: AbbVie Inc. - Key news
  • Exhibits118: AbbVie Inc. - Key offerings
  • Exhibits119: Acerus Pharmaceuticals Corp. - Overview
  • Exhibits120: Acerus Pharmaceuticals Corp. - Product / Service
  • Exhibits121: Acerus Pharmaceuticals Corp. - Key offerings
  • Exhibits122: Alembic Pharmaceuticals Ltd. - Overview
  • Exhibits123: Alembic Pharmaceuticals Ltd. - Product / Service
  • Exhibits124: Alembic Pharmaceuticals Ltd. - Key offerings
  • Exhibits125: Amneal Pharmaceuticals Inc. - Overview
  • Exhibits126: Amneal Pharmaceuticals Inc. - Business segments
  • Exhibits127: Amneal Pharmaceuticals Inc. - Key news
  • Exhibits128: Amneal Pharmaceuticals Inc. - Key offerings
  • Exhibits129: Amneal Pharmaceuticals Inc. - Segment focus
  • Exhibits130: Bausch Health Companies Inc. - Overview
  • Exhibits131: Bausch Health Companies Inc. - Business segments
  • Exhibits132: Bausch Health Companies Inc. - Key news
  • Exhibits133: Bausch Health Companies Inc. - Key offerings
  • Exhibits134: Bausch Health Companies Inc. - Segment focus
  • Exhibits135: Bayer AG - Overview
  • Exhibits136: Bayer AG - Business segments
  • Exhibits137: Bayer AG - Key news
  • Exhibits138: Bayer AG - Key offerings
  • Exhibits139: Bayer AG - Segment focus
  • Exhibits140: Cipla Ltd. - Overview
  • Exhibits141: Cipla Ltd. - Business segments
  • Exhibits142: Cipla Ltd. - Key news
  • Exhibits143: Cipla Ltd. - Key offerings
  • Exhibits144: Cipla Ltd. - Segment focus
  • Exhibits145: Eli Lilly and Co. - Overview
  • Exhibits146: Eli Lilly and Co. - Product / Service
  • Exhibits147: Eli Lilly and Co. - Key news
  • Exhibits148: Eli Lilly and Co. - Key offerings
  • Exhibits149: Endo International Plc - Overview
  • Exhibits150: Endo International Plc - Business segments
  • Exhibits151: Endo International Plc - Key news
  • Exhibits152: Endo International Plc - Key offerings
  • Exhibits153: Endo International Plc - Segment focus
  • Exhibits154: Ferring BV - Overview
  • Exhibits155: Ferring BV - Product / Service
  • Exhibits156: Ferring BV - Key offerings
  • Exhibits157: Halozyme Therapeutics Inc. - Overview
  • Exhibits158: Halozyme Therapeutics Inc. - Product / Service
  • Exhibits159: Halozyme Therapeutics Inc. - Key offerings
  • Exhibits160: Marius Pharmaceuticals - Overview
  • Exhibits161: Marius Pharmaceuticals - Product / Service
  • Exhibits162: Marius Pharmaceuticals - Key offerings
  • Exhibits163: Pfizer Inc. - Overview
  • Exhibits164: Pfizer Inc. - Product / Service
  • Exhibits165: Pfizer Inc. - Key news
  • Exhibits166: Pfizer Inc. - Key offerings
  • Exhibits167: Sawai Pharmaceutical Co. Ltd. - Overview
  • Exhibits168: Sawai Pharmaceutical Co. Ltd. - Business segments
  • Exhibits169: Sawai Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits170: Sawai Pharmaceutical Co. Ltd. - Segment focus
  • Exhibits171: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits172: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits173: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits174: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits175: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits176: Inclusions checklist
  • Exhibits177: Exclusions checklist
  • Exhibits178: Currency conversion rates for US$
  • Exhibits179: Research methodology
  • Exhibits180: Validation techniques employed for market sizing
  • Exhibits181: Information sources
  • Exhibits182: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!